Kestra Medical Technologies Files 8-K on Security Holder Vote
Ticker: KMTS · Form: 8-K · Filed: Sep 4, 2025 · CIK: 1877184
| Field | Detail |
|---|---|
| Company | Kestra Medical Technologies, LTD. (KMTS) |
| Form Type | 8-K |
| Filed Date | Sep 4, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
KESTRA shareholders voted on something important on Sept 3rd. Details TBD.
AI Summary
Kestra Medical Technologies, Ltd. filed an 8-K on September 4, 2025, reporting on a matter submitted to a vote of its security holders on September 3, 2025. The filing does not disclose the specific details of the vote or the outcome.
Why It Matters
This filing indicates a significant event where shareholders voted on a matter, which could impact the company's future direction or governance.
Risk Assessment
Risk Level: medium — The filing is an 8-K reporting a vote, which suggests a material event has occurred or is being addressed, but the lack of specific details introduces uncertainty.
Key Players & Entities
- KESTRA MEDICAL TECHNOLOGIES, LTD. (company) — Registrant
- September 3, 2025 (date) — Date of earliest event reported
- September 4, 2025 (date) — Date of report
- 3933 Lake Washington Blvd NE Suite 200 (address) — Principal Executive Offices
- Kirkland, Washington (location) — Principal Executive Offices Location
- 98033 (zip_code) — Principal Executive Offices Zip Code
- (425) 279-8002 (phone_number) — Registrant's Telephone Number
FAQ
What specific matter was submitted to a vote of Kestra Medical Technologies' security holders?
The filing does not specify the exact matter that was submitted to a vote of security holders on September 3, 2025.
What was the outcome of the vote by Kestra Medical Technologies' security holders?
The filing does not disclose the results or outcome of the vote that took place on September 3, 2025.
When was the 8-K filing submitted to the SEC?
The 8-K filing was submitted to the SEC on September 4, 2025.
What is Kestra Medical Technologies' principal executive office address?
Kestra Medical Technologies' principal executive office is located at 3933 Lake Washington Blvd NE, Suite 200, Kirkland, Washington 98033.
Is Kestra Medical Technologies incorporated in the US?
No, Kestra Medical Technologies, Ltd. is incorporated in Bermuda.
Filing Stats: 609 words · 2 min read · ~2 pages · Grade level 14.5 · Accepted 2025-09-04 16:48:03
Key Financial Figures
- $1.00 — h registered Common Shares, par value $1.00 per share KMTS The Nasdaq Stock Mar
Filing Documents
- ck0001877184-20250903.htm (8-K) — 59KB
- 0000950170-25-113058.txt ( ) — 176KB
- ck0001877184-20250903.xsd (EX-101.SCH) — 33KB
- ck0001877184-20250903_htm.xml (XML) — 5KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. The Kestra Medical Technologies, Ltd. (the "Company") 2025 annual general meeting of shareholders (the "2025 Annual Meeting") was held on September 3, 2025. The total number of the Company's common shares voted in person or by proxy at the 2025 Annual Meeting was 48,835,102, representing approximately 95% of the 51,348,656 shares that were outstanding and entitled to vote as of July 7, 2025, the record date of the 2025 Annual Meeting. Voting results for each matter submitted to a vote at the 2025 Annual Meeting are provided below. Proposal 1 – Election of Directors The shareholders elected each of the two persons named below to serve as Class I directors until the Company's 2028 annual meeting of shareholders and until their successors are duly elected and qualified, with the vote totals as set forth in the table below: Nominee For Against Abstain Conor Hanley 43,121,331 3,640,519 14,870 Elizabeth Kwo 43,118,417 3,643,439 14,864 Proposal 2 – Ratification of Independent Registered Public Accounting Firm The shareholders ratified the appointment of PricewaterhouseCoopers as the Company's independent registered public accounting firm for the fiscal year ending April 30, 2026, with the vote totals set forth in the table below: For Against Abstain 48,814,793 5,444 14,865 Proposal 3 – Approval of 2025 Employee Stock Purchase Plan The shareholders approved the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan, with the vote totals set forth in the table below: For Against Abstain 45,801,106 975,504 110
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Kestra Medical Technologies, Ltd. Date: September 4, 2025 By: /s/ Brian Webster Name: Brian Webster Title: President and Chief Executive Officer